LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized Music Treatment for Alzheimer’s Disease
Alzheimer’s Digital Therapeutic to Unlock the Power of Music Therapy TORONTO--(BUSINESS WIRE)--12.7 million Americans aged 65 and older are projected to have Alzheimer’s dementia by 2050. LUCID and JT are now partnering on the development of a prescri...